60 results
Page 2 of 3
8-K
EX-1.1
k7303daoc2jm u6
8 Jan 21
Fate Therapeutics Announces Proposed Public Offering of $350 Million of Common Stock
4:02pm
424B5
p0fxqd
7 Jan 21
Prospectus supplement for primary offering
5:25pm
424B5
8vp0h
4 Jan 21
Prospectus supplement for primary offering
4:15pm
424B5
uslprr0h2d
10 Jun 20
Prospectus supplement for primary offering
12:00am
8-K
EX-1.1
cj37d9yv248l3d0
9 Jun 20
Fate Therapeutics Announces Proposed Public Offering of Common Stock
9:21pm
424B5
w6kj b2a437w
8 Jun 20
Prospectus supplement for primary offering
4:11pm
8-K
EX-1.1
i9d6fvunqh78ml lm
12 Sep 19
Fate Therapeutics Announces Proposed Public Offering of Common Stock
9:30pm
424B5
6cnpt5hte q30
12 Sep 19
Prospectus supplement for primary offering
9:25pm
424B5
ew94bgghaa4li29sw
11 Sep 19
Prospectus supplement for primary offering
4:08pm